Iron clues: Erythropoietin's hidden role in Body's mineral balance
NCT ID NCT00687518
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study looked at how a single injection of erythropoietin, a hormone that boosts red blood cell production, changes levels of hepcidin — a key protein that controls iron in the body. Fourteen healthy men aged 18–30 took part. Researchers measured hepcidin in blood and urine to better understand how the body adjusts iron during anemia or low oxygen.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Erythropoietin
- What this could lead to
- If successful, this could help explain how the body controls iron levels, potentially pointing toward better treatments for iron disorders.
- What could go wrong
- This is a very small, early-stage study in healthy volunteers, not patients. It only looks at short-term changes and may not apply to real-world disease.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for IRON METABOLISM DISORDERS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Unité d'Investigation Clinique - Centre d'Investigation Clinique - Hôpital de Pontchaillou
Rennes, 35033, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.